Medical Misfit

BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science-based access by removing 12 peptides from Category 2 and advancing them for formal review.   🔹 What does this mean? These peptides will be evaluated by independent experts using rigorous clinical, pharmacological, and safety data, reopening the path to potential use through licensed compounding pharmacies.   🔹 Why does this matter? Restrictions in 2023 limited access and pushed some patients toward unregulated sources, increasing safety risks.   This shift brings peptide therapy back into a more transparent, regulated process, supporting quality, safety, and clinician-guided care.   See the full list of 12 peptides in the comments below.

Peptides: tiny, precise, and no know toxic dosage. Sign me up!

Unlock the power of precision. 🧬 Peptides are changing the game when it comes to safety and effectiveness in wellness. Unlike many traditional supplements, they offer a targeted approach with virtually no toxic dose. Ready to rejuvenate your system? #Peptides #WellnessJourney #DrKentHoltorf

This Saturday from 2 pm to 4 pm EST, Dr. Ritchie Shoemaker and Dr. Scott McMahon from Moldco will be holding an AMA on Reddit.

Dr. Shoemaker is the physician who identified CIRS, created the first diagnostic and treatment protocol, published 40+ peer-reviewed papers, and has treated over 14,000 patients.

Dr. McMahon was the first physician to complete Dr. Shoemaker's CIRS Certification Program, has treated 2,000 patients, authored a book on mold toxicity, and co-authored 3 consensus statements and 10 peer-reviewed studies, including the most thorough paper to date on CIRS. He's MoldCo's Medical Director.

If you're currently dealing with mold-related illness, CIRS, or are curious about environmental illness, this is the perfect opportunity to ask questions. Here's how it works:

1. Drop your questions below, and we'll bring them into the room on the 18th.

2. At 2 pm EDT on Saturday, March 18th, Dr. Shoemaker and Dr. McMahon will start answering your questions.

3. Answers will appear as replies under the MoldCo account. You'll be able to come read them here and visit the post both during and after the AMA.

Submit your questions here on Reddit: https://tinyurl.com/yma8dx8y

Desperate Times, Desperate Rentals: I will be going live tomorrow at 11:00 am for my first episode of a series of lives I'm calling Desperate Times, Desperate Rentals. In it, I will be sharing my home or desperate rental and the circumstances that got me to this point with you. You can join me on my TikTok:

Medical Misfit on TikTok .rosheck 85 Followers, 23 Following, 237 Likes - Watch awesome short videos created by Medical Misfit

Change is in the air in the peptide industry, which is a good thing. The days of unregulated, research-only peptides available to anyone with an internet connection and a credit card are swiftly shrinking in the rearview mirror. It signals the end of a time when people who wanted or needed the health benefits offered through peptide therapy were forced to take matters into their own hands. Healthcare is starting to catch up, and this is only the beginning.

https://www.instagram.com/reel/DW4-Jy5EVKJ/?igsh=MTl5dnp1Y2Vqd2NqMA==

What just happened in the peptide industry and what it means for you 😱👇 1. Major supplier shut down — One of the giants in the research-use space just closed its doors. For some this feels uncertain. In reality, it signals something important. 2. FDA watching closely — Enforcement isn’t random. It’s targeting mass marketing, consumer-facing claims, and unclear distribution models. If your practice looks like a retail operation, you’re a target. 3. State boards activated — State boards are becoming more active. Oversight is tightening. What was tolerated 2 years ago is now getting flagged. Practices are being reviewed. 4. Research-use closing — Research use has not been regulated. What’s on the bottle isn’t necessarily in the bottle. It can become dangerous. This era is ending. Good. 5. Peptides aren’t going away — The public demand for wellness and direct access is not going away. I don’t see any kind of shrinking away from public demand for access. 6. Access is changing — From unregulated consumer channels to clinician-led, compliant frameworks. The molecule stays. The Wild West disappears. 7. Educated clinicians win — Welcome to the future of Healthcare 3.0. Peptides are here to stay. You want to learn more, follow us. This isn’t something to fear. It’s something to prepare for. The clinicians who invested in real education, compliance, and frameworks aren’t disrupted by regulation — they’re strengthened by it. If you want to understand how to position your practice for what’s coming — follow for more... @mypeptideuniversity

If hormones can be considered the foundation, then peptides are the fine-tuning dial.

Unlike medication which does one thing at the expense of unbalancing everything else, peptides are pleiotropic working with your body to accomplish it's goal. From brain health and improving sleep to gut repair and mitochondrial health, the reach and impact of peptide therapy on improving health cannot be denied.

The Power of Peptides 🧬 Think of hormones as the foundation and peptides as the fine-tuning dial.Unlike standard medications that often have a "broad-stroke" effect, peptides work i...

Microplastics, PFAs, Pharmaceuticals, and Others added to the Sixth Contaminant Candidate List to Safeguard Drinking Water

The EPA and HHS have teamed up to address the growing and urgent concern of microplastics contamination, a first in the history of the EPA. Microplastics, along with pharmaceuticals, PFAs, disinfection byproducts, 75 chemicals, and nine microbes that may be present in our drinking water, have now been added to the draft Six Contaminant Candidate List (CCL 6).

The CCL is a tool under the Safe Drinking Water Act (SDWA) that drives research, funding, and future decisions on regulating emerging threats to drinking water. This will be used in tandem with the recently launched program called STOMP (Systemic Targeting of Microplastics) to hopefully better protect our drinking water. andOthers

The EPA and HHS has teamed up to address the growing and urgent concern of microplastics contamination, a first in the history of EPA. Microplastics along with pharmaceuticals, PFAs, disinfection byproducts, 75 chemicals, and nine microbes that maybe present in our drinking water have now been added to the draft Six Contaminant Candidate List (CCL 6).

The CCL is a tool under the Safe Drinking Water Act (SDWA) that drives reaseach, funding, and future decisions on regulating emerging threats to drinking water. This will be used in tandem with the recently lauched program called STOMP (Systemic Targeting of Microplastics) to hopefully better protect our drinking water. i. or the for.sa

https://www.epa.gov/newsreleases/epa-hhs-announce-historic-actions-protect-americans-microplastics-and-safeguard

Microplastics are everywhere. Our food, drinking water, and the air we breathe, all contain microplastics, but how does this affect our health? That's a big question that we don't yet have the answer to, as science hasn't kept up with the production of plastics and how they infiltrate the human body. Currently, we know that microplastics have been found in the human body, which is a shared concern, but we do not have a standard way to measure exposure, nor do we know how that exposure impacts the brain, nervous system, reproductive system, and overall health. It appears that may change soon.

Yesterday, HHS announced a new $144 million program called STOMP (Systematic Targeting Of MicroPlastics) that will create the definitive toolbox for measuring, researching, and affordably removing microplastics and nanoplastics (MNPs) in the human body. This work will also produce a ranking system for plastics that will rate each type of plastic according to the biological harm they present, allowing us to know which microplastics need to be addressed first and how. This is especially great news for vulnerable groups such as pregnant women, children, patients with chronic disease, and highly exposed workers.

I'm looking forward to seeing where this takes us.

https://www.hhs.gov/press-room/arpa-h-launches-groundbreaking-144-million-program-combat-toxic-microplastics-human-body.html

https://arpa-h.gov/explore-funding/programs/stomp